Acorda Therapeutics (ACOR) Beats by $0.04

Acorda Therapeutics, Inc. (ACOR) shares are down 1.46% to $36.35 in recent trading following the drugmaker’s fourth quarter earnings results. The Ardsley, New York-based company reported earnings of $0.46 per share on revenues of $117.9 million, up 27.3% from a year ago. Analysts were expecting EPS of $0.42 on revenues of $103.7 million. For the […] View the full post at: Acorda Therapeutics (ACOR) Beats by $0.04 Related posts: JPMorgan Posts Better-than-Expected Results Insider Selling: Twitter (TWTR) CEO Unloads $5M Worth of Stock 4Kids Entertainment Puts Itself Up for Sale